Biocon Ltd. | BIOCON | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Net Income
Net Income
10,026
8,709
8,462
7,716
6,430
Cash flow Operating Act...
Cash flow Operating Activities
11,54612,83111,59711,76618,525
Investments in PPE
Investments in PPE
-12,221-16,042-17,463-16,978-15,960
Cash flow Investing Act...
Net cash used for Investment Activities
-7,138-15,589-36,247-16,991-142,818
Dividend Paid
Dividend Paid
79370100718
Cash flow Financing Act...
Net cash provided by Financing Activities
-2,4173,87625,6402,421130,487
Cash at beginning of period
Cash at beginning of period
4,4906,5938,2478,9706,537
Cash at end of period
Cash at end of period
6,5938,2478,9706,53712,948
Free Cash Flow
Free Cash Flow
-675
-3,211
-5,866
-5,212
2,565